أعرض في EDS

Multicenter phase 2 trial of varlitinib versus lapatinib in combination with capecitabine in patients with HER2+ metastatic breast cancer (MBC) who failed prior trastuzumab therapy

التفاصيل البيبلوغرافية
العنوان: Multicenter phase 2 trial of varlitinib versus lapatinib in combination with capecitabine in patients with HER2+ metastatic breast cancer (MBC) who failed prior trastuzumab therapy
المؤلفون: Joanne Wing Yan Chiu, Seungje Lee, C-L. Liu, A. Chan, H-K Chang, S-C Chen, C-Y. Hsieh, B. Lindmark, M-S Dai, J.L. Peneyra, Bridget A. Robinson, L-M Tseng, N. McIntyre, W.Y. Chay, K-M Rau, A.A. Guancia, L.W.C. Chow, M. Head, H-C. Wang, G.E. Lee
المصدر: Annals of Oncology. 28:x30
بيانات النشر: Elsevier BV, 2017.
سنة النشر: 2017
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Hematology, VARLITINIB, Lapatinib, medicine.disease, Metastatic breast cancer, Capecitabine, 03 medical and health sciences, 030104 developmental biology, Trastuzumab, Internal medicine, medicine, In patient, business, medicine.drug
تدمد: 0923-7534
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4357fc6e9b2d67e61ab1d91ce5abe5adTest
https://doi.org/10.1093/annonc/mdx654.010Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........4357fc6e9b2d67e61ab1d91ce5abe5ad
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534